Clinical Trials Browser

Phase 1/2 × Completed × Leukemia, Lymphoid × Clear all

Brain Neoplasms, Breast Neoplasms, Leukemia, Lymphoid, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00935792 2017-09-26

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 1/2 Completed

28 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Lymphoid, Hematologic Neoplasms

NCT01471782 2017-02-08

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Phase 1/2 Completed

93 enrolled 21 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01105247 2014-03-31

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

Phase 1/2 Completed

133 enrolled 10 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT00035022 2006-01-13

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

Phase 1/2 Completed

71 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphoid, Lymphoma

Clinical Trials

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas